1. Please provide the total number of patients treated in the last 3 months with any systemic anti-cancer treatment for:
a. Prostate cancer (any stage)
b. Metastatic prostate cancer
2. How many patients were treated for prostate cancer (any stage) in the past 3 months with:
a. Androgen Deprivation Therapy (ADT) standalone
b. Abiraterone (Zytiga) in combination with any ADT
c. Abiraterone (Zytiga) – no ADT
d. Enzalutamide (Xtandi) in combination with any ADT
e. Enzalutamide (Xtandi) – no ADT
f. Apalutamide (Erleada) in combination with any ADT
g. Darolutamide (Nubeqa) in combination with any ADT
h. Cabazitaxel (Jevtana)
i. Docetaxel in combination with any ADT
j. Docetaxel – no ADT
k. Degarelix (Firmagon)
l. Olaparib (Lynparza)
3. How many metastatic prostate cancer patients were treated in the past 3 months with:
a. Androgen Deprivation Therapy (ADT) standalone
b. Apalutamide (Erleada) in combination with any ADT
c. Docetaxel in combination with any ADT
d. Docetaxel – no ADT
